Skye Biologics Holdings LLC – 654466

Delivery Method: VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED Reference #: CBER-24-654466 Product: Biologics Recipient: Recipient Name Christopher M.B. Sharp Recipient Title Chief Executive Officer Skye Biologics Holdings LLC 2255 Campus DrEl Segundo, CA...

Sarfez Pharmaceuticals, Inc. – 708901

Recipient: []Recipient Name []Salim Shah, PhD, JD []Recipient Title []Founder/President/CEO Sarfez Pharmaceuticals, Inc. []8000 Towers Crescent Drive Suite 1302Vienna, VA 22182United States Issuing Office: Center for Drug Evaluation and Research (CDER) []United States...

Combination Products Performance Reports

The Medical Device User Fee and Modernization Act (MDUFMA) requires the HHS Secretary to submit an annual report to Congress on the activities and impact of the Office of Combination Products (OCP). The report focuses on OCP’s efforts to ensure the prompt assignment...

NUVAXOVID

STN: 125817Proper Name: COVID-19 Vaccine, AdjuvantedTradename: NUVAXOVIDManufacturer: Novavax, Inc.Indication: NUVAXOVID is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome...

Biomarker Qualification Program

 To locate a project or a qualified biomarker go to CDER & CBER’s DDT Qualification Project Search databaseWeb content is updated for consistency with 21st Century Cures Act!Get started with your submissionResources for Biomarker RequestorsMissionThe mission of...